ITP vs. FNAIT in Pregnancy: What's the Difference?

If you have a history of Immune Thrombocytopenia (ITP), it is completely understandable to worry about how it might affect your baby’s platelets. The most important thing to know is that ITP and FNAIT are entirely different conditions ^[1][2]. Having ITP does not mean your baby will develop Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) during your pregnancy ^[2][3].

While both conditions involve the immune system and platelets, they work in fundamentally different ways. ITP is an autoimmune condition, meaning your body attacks your own platelets ^[2][4]. FNAIT is an alloimmune condition, meaning the mother’s immune system is perfectly healthy but reacts to the baby’s foreign platelets as if they were an invader, similar to Rh disease ^[1].

Autoimmune vs. Alloimmune: What’s the Difference?

To understand why these conditions are different, it helps to look at exactly what the immune system is targeting.

• In Maternal ITP (Autoimmune): Your immune system makes “autoantibodies” that get confused and target your own platelets for destruction ^[2]. Because of this, mothers with active ITP usually have low platelet counts themselves (though if your ITP is well-managed or in remission, your counts might be normal) ^[2]. These antibodies can sometimes cross the placenta and temporarily lower the baby’s platelets, but this is typically mild and resolves on its own ^[2][5].
• In FNAIT (Alloimmune): Your immune system is functioning normally and is not attacking your own platelets. Instead, it recognizes specific proteins (antigens) on the baby’s platelets—which they inherited from their father—as foreign ^[1]. The mother produces “alloantibodies” against these foreign proteins. Crucially, a mother carrying a baby with FNAIT will usually have completely normal platelet counts, because her own platelets are not being attacked ^[6].

How They Affect the Baby

While both ITP and FNAIT can result in a baby being born with low platelets (neonatal thrombocytopenia), the severity is very different ^[1].

• Neonatal Thrombocytopenia from ITP: If maternal ITP antibodies cross the placenta, the baby’s platelets might drop. However, severe bleeding complications in the newborn are rare ^[2]. Doctors will closely monitor both your platelet count during pregnancy and your baby’s platelet count during and after delivery (typically starting with a blood test right after birth) to ensure they do not need treatment ^[7].
• FNAIT: Because the mother’s antibodies are specifically targeting the baby’s unique platelet proteins, FNAIT tends to cause a much more severe drop in the baby’s platelets ^[1]. It is a leading cause of severe newborn thrombocytopenia and carries a higher risk of serious bleeding complications, such as intracranial hemorrhage (bleeding in the brain) ^[6][8]. Because this dangerous bleeding can happen in utero (before the baby is even born) ^[6], doctors will often treat the mother during pregnancy (such as with IVIG) to protect the baby ^[9][10].

Summary of Key Differences

If you have a history of ITP, your obstetrician or a maternal-fetal medicine specialist will monitor your pregnancy closely to ensure you and your baby remain safe ^[7][4]. However, you do not need to worry that your ITP is turning into or causing FNAIT. They remain two separate conditions with two distinct management paths.